QXL Stock Analysis: Quantum X Labs | NASDAQ
Information Technology Services | NASDAQ, USA | Market Cap: 84m USD | 12M Return: 34.5% | US9267113002 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 168K
Rev. Trend: -97.3%
Warnings
Tailwinds
Seasonality
Quantum X Labs Inc. (NASDAQ: QXL), based in Ramat Gan, Israel, develops quantum computing technologies, including error correction, simulation and sensing, alongside enterprise AI and digital advertising businesses. Its targeted applications include drug discovery, navigation, transportation and cybersecurity.
Quantum computing is an emerging field, with error-correction technologies designed to help address the effects of noise in quantum systems. The company was formerly known as Viewbix Inc. and changed its name in April 2026.
- Quantum technology commercialization and customer wins drive revenue traction
- AI and digital advertising growth may offset long quantum sales cycles
- R&D spending and financing needs risk margin pressure and shareholder dilution
| Net Income: -2.08m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.10 > 0.02 and ΔFCF/TA -16.68 > 1.0 |
| NWC/Revenue: -35.05% < 20% (prev -171.3%; Δ 136.3% < -1%) |
| CFO/TA -0.12 > 3% & CFO -3.60m > Net Income -2.08m |
| Net Debt (-530k) to EBITDA (1.92m): -0.28 < 3 |
| Current Ratio: 0.86 > 1.5 & < 3 |
| Outstanding Shares: last quarter (20.1m) vs 12m ago 177.4% < -2% |
| Gross Margin: 81.07% > 18% (prev 65.18%; Δ 15.89% > 0.5%) |
| Asset Turnover: 6.12% > 50% (prev 24.72%; Δ -18.60% > 0%) |
| Interest Coverage Ratio: 3.45 > 6 (EBIT TTM 1.07m / Interest Expense TTM 310k) |
| A: -0.02 (Total Current Assets 3.50m - Total Current Liabilities 4.05m) / Total Assets 31.2m |
| B: -1.42 (Retained Earnings -44.2m / Total Assets 31.2m) |
| C: 0.04 (EBIT TTM 1.07m / Avg Total Assets 25.6m) |
| D: 4.79 (Book Value of Equity 25.8m / Total Liabilities 5.38m) |
| Altman-Z'' = 0.57 = B |
| DSRI: 0.85 (Receivables 281k/1.05m, Revenue 1.57m/4.97m) |
| GMI: 0.80 (GM 65.18% / 81.07%) |
| AQI: 1.12 (AQ_t 0.88 / AQ_t-1 0.79) |
| SGI: 0.32 (Revenue 1.57m / 4.97m) |
| TATA: 0.05 (NI -2.08m - CFO -3.60m) / TA 31.2m) |
| Beneish M = -3.74 (Cap -4..+1) = AAA |
As of October 18, 2026, the stock is trading at USD 4.41 with a total of 155,221 shares traded. Over the past week, the price has changed by +12.21%, over one month by -22.63%, over three months by -8.32% and over the past year by +34.45%.
Current recommended Stop Loss: 3.70 (which is 16.1% or 1.6 ATR below the current price).
Quantum X Labs has no consensus analysts rating.
P/E Trailing = 6.2565
P/S = 63.5726
P/B = 2.8449
Revenue TTM = 1.57m USD
EBIT TTM = 1.07m USD
EBITDA TTM = 1.92m USD
Long Term Debt = 195k USD (from longTermDebt, last quarter)
Short Term Debt = 1.71m USD (from shortTermDebt, last quarter)
Debt = 1.91m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -530k USD (calculated: Debt 1.91m - CCE 2.44m)
Enterprise Value = 83.1m USD (83.7m + Debt 1.91m - CCE 2.44m)
Interest Coverage Ratio = 3.45 (Ebit TTM 1.07m / Interest Expense TTM 310k)
EV/FCF = -27.45x (Enterprise Value 83.1m / FCF TTM -3.03m)
FCF Yield = -3.64% (FCF TTM -3.03m / Enterprise Value 83.1m)
FCF Margin = -193.1% (FCF TTM -3.03m / Revenue TTM 1.57m)
Net Margin = -132.5% (Net Income TTM -2.08m / Revenue TTM 1.57m)
Gross Margin = 81.07% ((Revenue TTM 1.57m - Cost of Revenue TTM 297k) / Revenue TTM)
Gross Margin QoQ = 54.27% (prev 62.61%)
Tobins Q-Ratio = 2.67 (Enterprise Value 83.1m / Total Assets 31.2m)
Interest Expense / Debt = 16.27% (Interest Expense 310k / Debt 1.91m)
Taxrate = 0.09% (4.00k / 4.68m)
NOPAT = 1.07m (EBIT 1.07m * (1 - 0.09%))
Current Ratio = 0.86 (Total Current Assets 3.50m / Total Current Liabilities 4.05m)
Debt / Equity = 0.07 (Debt 1.91m / totalStockholderEquity, last quarter 25.8m)
Debt / EBITDA = -0.28 (Net Debt -530k / EBITDA 1.92m)
Debt / FCF = 0.17 (negative FCF - burning cash) (Net Debt -530k / FCF TTM -3.03m)
Total Stockholder Equity = 14.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -8.11% (Net Income -2.08m / Total Assets 31.2m)
RoE = -14.35% (Net Income TTM -2.08m / Total Stockholder Equity 14.5m)
RoCE = 7.28% (EBIT 1.07m / Capital Employed (Equity 14.5m + L.T.Debt 195k))
RoIC = 3.71% (NOPAT 1.07m / Invested Capital 28.8m)
WACC = 13.73% (E(83.7m)/V(85.6m) * Re(13.67%) + D(1.91m)/V(85.6m) * Rd(16.27%) * (1-Tc(0.00)))
Discount Rate = 13.67% (= CAPM, Blume Beta Adj.) -> capped to 12.54%
Shares (quarterly) Correlation: 90.25 | Cagr: 143.1%
[DCF] Fair Price = unknown (Cash Flow -3.03m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: -97.27 | Revenue CAGR: -85.96% | SUE: N/A | # QB: 0